ArticleInfection Control Considerations in Interventional Pain ManagementGevirtz, Clifford MD, MPH Author Information Dr. Gevirtz is Associate Professor of Anesthesiology, Louisiana State University-New Orleans Health Center, and Medical Director, Somnia Pain Management, 627 West Street, Harrison, NY 10528; E-mail: [email protected]. Dr. Gevirtz has disclosed that he has no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity. Dr. Gevirtz also has disclosed that prophylactic use of cefoxitin and vancomycin as discussed in this article has not been approved by the U.S. Food and Drug Administration. All staff in a position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity. Lippincott CME Institute, Inc., has identified and resolved all faculty and staff conflicts of interest regarding this educational activity. Topics in Pain Management 24(12):p 1-6, July 2009. | DOI: 10.1097/01.TPM.0000357113.34121.d5 Buy CME Test Metrics Copyright © 2009 Wolters Kluwer Health, Inc. All rights reserved.